Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Apr 27, 2016, 17:18 ET BiondVax Announces Fourth Quarter and Full Year 2015 Financial Results and Update

 BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV, TASE: BVXV), a clinical stage biopharmaceutical company focused on developing and commercializing...


Apr 27, 2016, 16:00 ET HeartWare Completes Enrollment In HVAD® System LATERAL Study™

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are...


Apr 27, 2016, 14:45 ET Researcher Launches First RSV Trial of its Kind in Four Decades

 Delivering on a Promise is a publication highlighting Le Bonheur Children's Hospital's newest programs, research breakthroughs and...


Apr 27, 2016, 14:32 ET L'entreprise Strekin AG, spécialisée dans le domaine des sciences de la vie, annonce le lancement d'une étude clinique de phase 2 portant sur le STR001, nouveau traitement possible de la perte d'audition

Au Sachs CEO forum à Zurich, Strekin AG a annoncé le lancement d'une étude clinique de phase 2 de son principal...


Apr 27, 2016, 14:31 ET Life-Science-Startup-Unternehmen Strekin AG kündigt Start einer klinischen Phase-II-Studie von STR001 zur Behandlung von Schwerhörigkeit an

Im Rahmen des Sachs CEO Forums in Zürich gab Strekin AG den Start einer klinischen Phase-II-Studie ihres führenden Wirkstoffkandidaten...


Apr 27, 2016, 12:18 ET Sanofi US Collaborates with Duke University and Massachusetts General Hospital on Big Data and Type 2 Diabetes

Sanofi US announced today collaborations with the Duke Clinical Research Institute (DCRI) and, separately, with the Center for Assessment...


Apr 27, 2016, 12:00 ET Transformative Potential of Elekta's High-field MR-guided Linear Accelerator Highlighted in Seven Abstracts at ESTRO 35

Elekta today announced that its leading-edge high-field MR-guided linear accelerator (MR-linac) platform will be the focal point of seven...


Apr 27, 2016, 11:59 ET IBC Generium Selects Goodwin Biotechnology to Optimize the Process, Scale-Up, and Manufacture an IgG-based Bispecific Antibody for Phase I Clinical Trials

 International Biotechnology Center "Generium", (LLC IBC Generium), a private scientific research company in Russia that is committed...


Apr 27, 2016, 10:00 ET BERG Initiates Phase II Combination Trial Of BPM 31510 And Gemcitabine In Patients With Pancreatic Cancer

 BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that it has...


Apr 27, 2016, 10:00 ET Oasmia Pharmaceutical verkündet positive allgemeine Überlebensergebnisse von der Phase-III-Studie mit Apealea/Paclical für die Behandlung von Eierstockkrebs

Die Daten zur Gesamtüberlebensrate aus der Phase-III-Studie erreichen den primären Endpunkt und belegen, dass die Bevorzugung von...


Apr 27, 2016, 09:00 ET Scientists Teaching Machines to Make Clinical Trials More Successful

 Scientists are teaching computers to figure out why people accept or decline invitations to participate in clinical trials. Recruiting...


Apr 27, 2016, 08:00 ET Cumberland Pharmaceuticals Announces New Program To Develop Vasculan™ For Systemic Sclerosis

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on the development of innovative treatments for...


Apr 27, 2016, 08:00 ET BBI Begins Enrolling Pivotal Trial Evaluating SEM Scanner for the Early Detection of Pressure Ulcers

 BBI, LLC, a developer of innovative sensor-based diagnostic products, today announced the initiation of a multi-center, pivotal clinical trial...


Apr 27, 2016, 07:00 ET Oasmia Pharmaceutical Announces Positive Overall Survival Results From Phase III Study of Apealea/Paclical for Treatment of Ovarian Cancer

Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, today announced positive...


Apr 27, 2016, 07:00 ET Biocept Collaborates with MedStar Georgetown University Hospital for Liquid Biopsy Study

Biocept, Inc. (NASDAQ: BIOC), a leading molecular diagnostics company with a commercial liquid biopsy technology focused on cancer treatment and...


Apr 27, 2016, 04:42 ET Life Science Startup Company Strekin AG Announces the Launch of a Phase 2 Clinical Study of STR001 as a Potential New Treatment for Hearing Loss

At the Sachs CEO forum in Zürich, Strekin AG announced the launch of a Phase 2 clinical study of its lead drug candidate, STR001, to preserve...


Apr 27, 2016, 04:05 ET Nanovi lanza un nuevo líquido marcador de tejido blando: BioXmark®

La aprobación de la Marca CE del marcador fiduciario de líquido de Nanovi, BioXmark®, crea nuevas oportunidades para la...


Apr 27, 2016, 02:30 ET Oasmia presenterar positiva överlevnadsdata från fas III-studie med Apealea/Paclical för behandling av äggstockscancer

Överlevnadsdata (Overall Survival data) från fas III-studien visade att studiemålet om non-inferiority gällande...


Apr 27, 2016, 01:25 ET Novartis receives three FDA Breakthrough Therapy Designations for Ilaris to treat rare types of Periodic Fever Syndromes

 Novartis today announced that the US Food and Drug Administration (FDA) has granted three Breakthrough Therapy Designations for Ilaris®...


Apr 27, 2016, 01:00 ET Le Journal of the American Medical Association publie les données de l'essai de Phase III dans le traitement de l'asthme allergique aux acariens de la poussière de maison avec le comprimé sublingual ACARIZAX® d'ALK

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) a annoncé aujourd'hui la publication par le Journal of the American Medical Association (JAMA)...


Most Viewed